Patient‑Derived Xenograft Model Market Expansion Supported by Rising Demand for Personalized Oncology
The increasing emphasis on personalized medicine and targeted cancer therapies is significantly transforming the global oncology research landscape. Patient-derived xenograft (PDX) models have emerged as a highly effective preclinical research tool that closely mimics human tumor biology, enabling researchers to study cancer progression, therapeutic response, and resistance mechanisms with...
0 Comments 0 Shares 75 Views 0 Reviews